Headlines
Madrigal Pharmaceuticals Reports 2017 Second Quarter Financial Results
August 10, 2017
Madrigal Pharmaceuticals Completes Enrollment in Phase 2 Proof-of-Concept Study with MGL-3196 for Treatment of NASH
August 1, 2017
Madrigal Pharmaceuticals Announces $35 Million Private Placement Offering
June 21, 2017
